Quarterly report pursuant to Section 13 or 15(d)

Stockholders??? Equity (Deficit)

v3.21.2
Stockholders’ Equity (Deficit)
6 Months Ended
Sep. 30, 2021
Stockholders' Equity Note [Abstract]  
Stockholders’ Equity (Deficit)

Note 8 - Stockholders’ Equity (Deficit)

 

Preferred Stock

 

As of September 30, 2021 and March 31, 2021, there were 50,000,000 authorized shares of the Company’s preferred stock, par value $0.0001.

 

Series A Preferred Sock

 

As of September 30, 2021 and March 31, 2021, the Company had 251 shares of its Series A preferred stock issued and outstanding.

 

Series B Preferred Stock

 

As of September 30, 2021 and March 31, 2021, the Company had 1,443 shares of its Series B preferred stock issued and outstanding.

 

Series C Preferred Stock

 

As of September 30, 2021 and March 31, 2021, the Company had 500,756 shares of its Series C preferred stock issued and outstanding.

 

Common Stock

 

Stock Issued for Services

 

During the six months ended September 30, 2021, the Company issued 64,261 shares of its common stock with a fair value of approximately $0.2 million in exchange for consulting services.

 

Stock Options

 

During the six months ended September 30, 2021, the Company issued 409,385 shares of its common stock in connection with the exercise of stock options and received proceeds of approximately $0.2 million.

 

During the year ended March 31, 2021, the Company issued 25,000 shares of its common stock in connection with the exercise of stock options, with an exercise price of $0.15 per share. During April 2021, the Company received the related proceeds of $3,750.